Your session is about to expire
← Back to Search
Other
Blood flow restriction and standard of care therapy for Patellofemoral Pain Syndrome
N/A
Waitlist Available
Led By Eric Sokolowski
Research Sponsored by Gaylord Hospital, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this assessment will be collected 12 months post start date.
Awards & highlights
Study Summary
This trial will study if a therapy can help improve outcomes for people with knee pain.
Eligible Conditions
- Patellofemoral Pain Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ this assessment will be collected 12 months post start date.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this assessment will be collected 12 months post start date.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Harm Reduction
Harm Reduction
Harm Reduction
+30 moreSecondary outcome measures
Quadricep Isometric Strength: 1 Week
Quadricep Isometric Strength: 4 Weeks
Quadricep Isometric Strength: 9 Weeks/Discharge
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Blood flow restriction and standard of care therapyExperimental Treatment1 Intervention
The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength.
Group II: Sham and standard of care therapyPlacebo Group1 Intervention
The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases.
Find a Location
Who is running the clinical trial?
Gaylord Hospital, IncLead Sponsor
6 Previous Clinical Trials
317 Total Patients Enrolled
UConn HealthOTHER
211 Previous Clinical Trials
60,620 Total Patients Enrolled
Eric SokolowskiPrincipal InvestigatorPhysical Therapist
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have received a knee injection in the past three months.You have a medical condition where your body is inflamed and it is not being controlled or treated.You have cancer in the same area where the treatment will be given, or below that area.Your diabetes is not well controlled and you have issues with numbness or poor blood flow in your limbs.You have had rhabdomyolysis in the past or currently have it.You have had surgery to remove lymph nodes.You have varicose veins or a history of blood clots in your deep veins or if your parents or siblings have had blood clots.You have wounds or pain below your knee that is severe, rated as a 4 out of 10 or higher.
Research Study Groups:
This trial has the following groups:- Group 1: Sham and standard of care therapy
- Group 2: Blood flow restriction and standard of care therapy
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger